您当前所在位置:首页 > 分析科学 > 新品上市
序号 标题 次数 作者 发布时间
77806 DOTA-(AEEA)2-BN DOTA-(AEEA)2-铃蟾肽 112 h 2024-12-19
77807 cas:2259318-55-1 , DBCO-(PEG2-VC-PAB-MMAE)2,ADC定制 119 wyh 2024-12-19
77808 cas:1394238-91-5 Fmoc-Val-Ala-PAB 140 zyl 2024-12-19
77809 CAS: 2285373-84-2 Ethyl (S)-1-((1-((4-((((4-nitrophenoxy)carbonyl) oxy)methyl)phenyl)amino)-1-oxo-5-ureidopenta n-2-yl)carbamoyl)cyclobutane-1-carboxylate 166 WYQ 2024-12-19
77810 Azido-Phenyl-Amido-SS-Sulfo-NHS Ester, ADC试剂 113 kx 2024-12-19
77811 DOTA-βala-K-NOTA-BBN(7-14)NH2 128 h 2024-12-19
77812 DBCO-PEG3-acetic-Val-Cit-PAB,主要用于合成抗体偶联药物(ADC) 117 WYQ 2024-12-19
77813 Mal-PEG4-Val-Ala-PAB-PNP,ADC定制 95 wyh 2024-12-19
77814 cas:330970-70-2 Alloc-Val-Ala-OH 116 zyl 2024-12-19
77815 DOTA-somatostatin receptor analogs DOTA生长抑素受体类似物 102 h 2024-12-19
77816 CAS: 2754384-60-4,DBCO-(PEG)3-VC-PAB-MMAE 96 WYQ 2024-12-19
77817 Fmoc-Gln(Trt)-PAB-OH, ADC试剂 133 kx 2024-12-19
77818 CAS: 2994332-18-0 ,DBCO-C4-Val-Cit-PABC-PNP,二苯并环辛炔-C4-缬氨酸-瓜氨酸-PABC-对硝基苯基磷酸酯 106 WYQ 2024-12-19
77819 cas:159857-60-0,Fmoc-Lys(MMt)-OH,N-[(9H-芴-9-基甲氧基)羰基]-N'-[(4-甲氧基苯基)二苯基甲基]-L-赖氨酸 203 kx 2024-12-19
77820 DBCO-PEG3-Val-Cit-PAB-PNP,二苯并环辛炔-三聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP 151 WYQ 2024-12-19
77821 NOTA-anti-HER2 NOTA标记抗人表皮生长因子受体2型(HER2)纳米体 134 h 2024-12-19
77822 cas:186023-44-9 Fmoc-Ala-Pro-OH 156 zyl 2024-12-19
77823 TCO-PEG4-Val-Cit-PAB-PNP,反式环辛烯-四聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP 114 WYQ 2024-12-19
77824 Boc-Val-Cit CAS:870487-08-4 132 zyl 2024-12-19
77825 DOTA-Bn-FGK-Fab DOTA标记抗体片段 133 h 2024-12-19
77826 cas:252554-78-2,Fmoc-Ala-Ser (Psi(Me,Me)pro)-OH,(4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 98 kx 2024-12-19
77827 DOTA-Nal3-Octreotide DOTANOC DOTA-Nal3-奥曲肽 119 h 2024-12-19
77828 cas:2413428-36-9,MC-Gly-Gly-Phe-Gly,(S)-5-苄基-18-(2,5-二氧代-2,5-二氢-1H-吡咯-1-基)-4,7,10,13-四氧代-3,6,9,12-四氮杂十八烷-1-酸 106 kx 2024-12-19
77829 MC-Val-Cit-PAB-PNP CAS:159857-81-5 156 zyl 2024-12-19
77830 cas:2353409-52-4,Mal-amido-PEG8-Val-Gly-PAB-OH,马来酰亚胺-酰胺-八聚乙二醇-VAL-GLY-PAB-羟基 83 kx 2024-12-19
77831 Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB CAS:2055042-69-6 99 zyl 2024-12-19
77832 cas:1895916-22-9,MC-Val-Ala-OH, ADC试剂 101 kx 2024-12-19
77833 cas:159857-70-2,MC-Val-Cit-Doxorubicin,MC-VAL-CIT-阿霉素 77 kx 2024-12-19
77834 DOTA−Gal-NAPamide DOTA−Gal-纳帕胺 86 h 2024-12-19
77835 DOTA-peptide-Lym-1 radioimmunotherapy DOTA-肽-Lym-1 111 h 2024-12-19
77836 N-DBCO-N-bis(PEG2-amide-PEG4-Val-cit-PAB-MMAE), N-二苯并环辛炔-N-双(二聚乙二醇-酰胺-四聚乙二醇-VAL-CIT-PAB-MMAE) 117 kx 2024-12-19
77837 DOTA-dGlu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 132 h 2024-12-19
77838 DOTA-MGO DOTA-DGlu-(Glu)s-minigastrin 95 h 2024-12-19
77839 cas:2762518-86-3,NHS Ester-PEG4-Val-Cit-PAB-MMAE, ADC试剂 142 kx 2024-12-19
77840 DOTA-scFv-anti-PSMA DOTA-scFv-抗PSMA脂质纳米粒(LNPs) 108 h 2024-12-19
77841 cas:2353409-45-5,BCN-PEG3-Val-Cit-PFP Ester, ADC试剂 96 kx 2024-12-19
77842 cas:2112738-13-1,Mal-amido-PEG2-Val-Cit-PAB-PNP, ADC试剂 88 kx 2024-12-19
77843 cas:2055041-39-7,Mal-PEG4-Val-Cit-PAB-OH, ADC试剂 91 kx 2024-12-19
77844 cas:2055024-62-7,NH2-PEG3-Val-Cit-PAB-OH, ADC试剂 147 kx 2024-12-19
77845 Fmoc-PEG3-Val-Cit,N-芴甲氧羰基-三聚乙二醇-VAL-CIT 122 kx 2024-12-19
77846 DOTA-anti-VLA-4 105 h 2024-12-19
77847 DOTA-glycylglycylglycyl-l-p-isothiocyanatophenylalanine amide 99 h 2024-12-19
77848 CAS: 2748039-76-9, Alkyne-Val-Cit-PAB-FAM,炔-Val-Cit-PAB-FAM 98 WYQ 2024-12-19
77849 CAS:646502-53-6 MC-Val-Cit-PAB-MMAE的结构式 134 zyl 2024-12-19
77850 Amino-PEG2-VG-N-Bis(PEG1-azide),氨基-二聚乙二醇-VG-N-双(一聚乙二醇-叠氮) 110 WYQ 2024-12-19
库存查询